The Aporia
Durbin, D. A. (2026, September 23). McDonald’s announces menu overhaul to cater to GLP-1 weight loss drug users. The Independent. https://www.independent.co.uk/news/world/americas/mcdonalds-new-menu-items-glp1-grilled-chicken-b3055189.html
Durbin, Dee-Ann. “McDonald’s announces menu overhaul to cater to GLP-1 weight loss drug users.” The Independent, 23 Sept. 2026, https://www.independent.co.uk/news/world/americas/mcdonalds-new-menu-items-glp1-grilled-chicken-b3055189.html.
Durbin, Dee-Ann. “McDonald’s announces menu overhaul to cater to GLP-1 weight loss drug users.” The Independent, September 23, 2026. https://www.independent.co.uk/news/world/americas/mcdonalds-new-menu-items-glp1-grilled-chicken-b3055189.html.
Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.
McDonald’s announced a $8.5 billion investment over ten years to revamp its global restaurants and cater to health-conscious diners, particularly those using GLP-1 weight loss drugs. The Chicago-based fast-food giant plans to introduce new menu items such as grilled chicken wraps, sandwiches, egg bowls, and bites that offer smaller portions with higher protein content. According to McDonald’s USA President Skye Anderson, 30 million Americans are currently taking GLP-1 medications, driving demand for healthier food options. The company will also feature dedicated pickup lockers for delivery drivers and open coffee stations to highlight beverage quality. This menu overhaul aims to retain existing customers as their dietary preferences shift towards higher protein intake.